SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001821825-21-000009
Filing Date
2021-08-16
Accepted
2021-08-16 08:20:13
Documents
94
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ogn-20210630.htm   iXBRL 10-Q 2388780
2 EX-31.1 ogn6302021ex311.htm EX-31.1 7687
3 EX-31.2 ogn6302021ex312.htm EX-31.2 7808
4 EX-32.1 ogn6302021ex321.htm EX-32.1 3784
5 EX-32.2 ogn6302021ex322.htm EX-32.2 3480
  Complete submission text file 0001821825-21-000009.txt   11314083

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ogn-20210630.xsd EX-101.SCH 77446
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ogn-20210630_cal.xml EX-101.CAL 112531
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ogn-20210630_def.xml EX-101.DEF 341703
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ogn-20210630_lab.xml EX-101.LAB 807129
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ogn-20210630_pre.xml EX-101.PRE 537866
11 EXTRACTED XBRL INSTANCE DOCUMENT ogn-20210630_htm.xml XML 2446360
Mailing Address 30 HUDSON STREET FL 33 JERSEY CITY NJ 07302
Business Address 30 HUDSON STREET FL 33 JERSEY CITY NJ 07302 551-430-6000
Organon & Co. (Filer) CIK: 0001821825 (see all company filings)

IRS No.: 464838035 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40235 | Film No.: 211174679
SIC: 2834 Pharmaceutical Preparations